Company intelligence / Profile preview

Digitalis Ventures

New York, New York, United Statesdigitalisventures.com ↗

Ownership: Private
Development stage: Other

Overview

Digitalis Ventures does not conduct clinical trials or develop drugs itself but invests in early-stage life science and health technology companies across the spectrum from preclinical to commercial stages via its portfolio.

Example portfolio highlights:

Companies developing small molecule targeted therapies for cancer.
Companies advancing gene/cell therapies and manufacturing platforms.
Companies working on diagnostics/tools enabling new scientific insights.

Therapeutic areas: OncologyPulmonologyOphthalmologyImmunology
Modalities: Small moleculeGene therapyCell therapyRNA therapyMonoclonal antibodyDiagnostics/toolsImmune tolerance-based biologicRadiopharmaceutical
Industry: Investors

Beyond the preview

Go deeper on Digitalis Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Digitalis Ventures.

Explore the full profile